Literature DB >> 3719593

Autoradiographic analysis of monoclonal antibody distribution in human colon and breast tumor xenografts.

P L Jones, B M Gallagher, H Sands.   

Abstract

The targeting of monoclonal antibodies to human tumor xenografts in nude mice was investigated by analysis of the cellular distribution of two radioiodinated monoclonal antibodies, B6.2 and B72.3, which recognize different tumor-associated antigens. The time course of distribution of each antibody within Clouser human mammary carcinoma (B6.2 positive, B72.3 negative) and LS174T human colorectal carcinoma (B6.2 positive, B72.3 positive) following i.v. injections was compared using autoradiographic techniques, which were also used to determine the pattern of binding after in vitro incubation with radiolabeled antibody. Both in vivo and in vitro localization of 125I-B72.3 in LS174T were characterized by the binding of antibody to antigen-rich mucin globules. In contrast, in vivo localization of B6.2 was restricted to groups of cells in well vascularized regions. Thus, the in vivo accumulations of B6.2 and B72.3 although quantitatively similar showed very different spatial distributions within LS174T tumors. The in vivo binding of B6.2 in Clouser tumors was restricted to small clusters of cells scattered fairly evenly throughout the tumor. There was no evidence for the presence of such antigen-rich foci after in vitro incubation of tumor sections with B6.2 suggesting that heterogeneity of regional uptake may be due to differences in antibody delivery. This type of information may provide a rational basis for the selection of appropriate therapeutic isotopes for radioimmunotherapy studies using these and other tumor models.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3719593     DOI: 10.1007/bf00199128

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  17 in total

1.  Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas.

Authors:  D Stramignoni; R Bowen; B F Atkinson; J Schlom
Journal:  Int J Cancer       Date:  1983-05-15       Impact factor: 7.396

2.  Tumour localisation of 211At-labelled monoclonal antibody to a sub-cutaneous human heterograft in the nude mouse II.

Authors:  W J Bateman; A T Vaughan; G Brown
Journal:  Int J Nucl Med Biol       Date:  1983

3.  Human colonic adenocarcinoma cells. I. Establishment and description of a new line.

Authors:  B H Tom; L P Rutzky; M M Jakstys; R Oyasu; C I Kaye; B D Kahan
Journal:  In Vitro       Date:  1976-03

4.  Imaging of melanoma with L-131-labeled monoclonal antibodies.

Authors:  S M Larson; J P Brown; P W Wright; J A Carrasquillo; I Hellström; K E Hellström
Journal:  J Nucl Med       Date:  1983-02       Impact factor: 10.057

5.  Localization of an anti-CEA monoclonal antibody in colo-rectal carcinoma xenografts.

Authors:  M V Pimm; N C Armitage; A C Perkins; W Smith; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  A spectrum of monoclonal antibodies reactive with human mammary tumor cells.

Authors:  D Colcher; P H Hand; M Nuti; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

7.  Radioimmunodetection of human tumor xenografts by monoclonal antibodies.

Authors:  D Herlyn; J Powe; A Alavi; J A Mattis; M Herlyn; C Ernst; R Vaum; H Koprowski
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

8.  Factors influencing localization of labeled antibodies in tumors.

Authors:  W F Bale; M A Contreras; E D Grady
Journal:  Cancer Res       Date:  1980-08       Impact factor: 12.701

9.  Human breast carcinoma: fibrin deposits and desmoplasia. Inflammatory cell type and distribution. Microvasculature and infarction.

Authors:  H F Dvorak; G R Dickersin; A M Dvorak; E J Manseau; K Pyne
Journal:  J Natl Cancer Inst       Date:  1981-08       Impact factor: 13.506

10.  Localization of human tumour xenografts after i.v. administration of radiolabeled monoclonal antibodies.

Authors:  V Moshakis; R A McIlhinney; D Raghavan; A M Neville
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640

View more
  10 in total

Review 1.  Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches.

Authors:  Niyanta N Kumar; Michelle E Pizzo; Geetika Nehra; Brynna Wilken-Resman; Sam Boroumand; Robert G Thorne
Journal:  Bioconjug Chem       Date:  2018-10-24       Impact factor: 4.774

2.  Proton relaxation times and interstitial fluid pressure in human melanoma xenografts.

Authors:  H Lyng; I Tufto; A Skretting; E K Rofstad
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors.

Authors:  Carol M Lee; Ian F Tannock
Journal:  BMC Cancer       Date:  2010-06-03       Impact factor: 4.430

4.  Improved modeling of in vivo kinetics of slowly diffusing radiotracers for tumor imaging.

Authors:  Moses Q Wilks; Scott M Knowles; Anna M Wu; Sung-Cheng Huang
Journal:  J Nucl Med       Date:  2014-07-03       Impact factor: 10.057

5.  Targeting cancer micrometastases with monoclonal antibodies: a binding-site barrier.

Authors:  T Saga; R D Neumann; T Heya; J Sato; S Kinuya; N Le; C H Paik; J N Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

6.  Improved radioimmunotherapy of colorectal cancer xenografts using antibody mixtures against carcinoembryonic antigen and colon-specific antigen-p.

Authors:  R D Blumenthal; R Kashi; R Stephens; R M Sharkey; D M Goldenberg
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

7.  Effect of tumor shape and size on drug delivery to solid tumors.

Authors:  M Soltani; Pu Chen
Journal:  J Biol Eng       Date:  2012-04-25       Impact factor: 4.355

8.  Numerical modeling of fluid flow in solid tumors.

Authors:  M Soltani; P Chen
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

9.  Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors.

Authors:  Dongxi Xiang; Conglong Zheng; Shu-Feng Zhou; Shuxi Qiao; Phuong Ha-Lien Tran; Chunwen Pu; Yong Li; Lingxue Kong; Abbas Z Kouzani; Jia Lin; Ke Liu; Lianhong Li; Sarah Shigdar; Wei Duan
Journal:  Theranostics       Date:  2015-07-02       Impact factor: 11.556

10.  Autoradiographic analysis of radiolabeled anti-carcinoembryonic antigen monoclonal antibody CEA102 in colorectal cancer using computed radiography.

Authors:  T Satoh; T Watanabe; M Tadokoro; J Sakamoto; H Murayama; K Itoh; S Sakuma; H Takagi
Journal:  Jpn J Cancer Res       Date:  1992-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.